Gossamer Bio Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Okay. Welcome to the afternoon sessions of the BofA Virtual Vegas Health Care Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA. Also, I have Olivia Brayer with me on the line from my team, and we're really excited to have Gossamer presenting today. And speaking on behalf of Gossamer, we have a few folks. We have CEO, Sheila Gujrathi; we have Bryan Giraudo who's CFO; and we have Richard Aranda who is Senior VP of Clinical Development. And so welcome, guys.
Sheila, do you want to say anything just to kick it off? Then we get ready into some questions.
Well, great. Thank you, Geoff and Olivia. Very excited to be at this virtual conference. It's been quite productive. So kudos to both of you and your teams for running such a successful conference. Really pleased to be here. Very excited to share updates we have for Gossamer despite the COVID-19 pandemic,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |